FGL1 and liver cancer: In addition, treatment with the steatogenic reagent, oleic acid, increased HPS expression, whereas the deletion of HPS reduced oleic acid-induced lipid accumulation in HepG2 cells, implying that HPS mediates the regulation of hepatic lipogenesis in liver cancer cells in vitro [19].